INO Inovio Pharmaceuticals

Watchlist

2.1500
+0.0200+0.94%

Close Feb 14 16:00 ET

2.1400
-0.0100-0.47%

Post 20:01 ET

77.61MMarket Cap-0.49P/E (TTM)

About Inovio Pharmaceuticals Company

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Company Profile

SymbolINO

Company NameInovio Pharmaceuticals

Listing DateDec 8, 1998

Founded1983

CEODr. Jacqueline E. Shea

MarketNASDAQ

Employees122

Fiscal Year Ends12-31

Address660 West Germantown Pike,Suite 110

CityPlymouth Meeting

ProvincePennsylvania

CountryUnited States of America

Zip Code19462-1111

Phone1-267-440-4200

Websitehttp://www.inovio.com

Company Executives

Name
Position
Salary

Dr. Jacqueline E. Shea
President, Chief Executive Officer and Director
2.07M

Peter D. Kies
Chief Financial Officer and Principal Accounting Officer
988.73K

Michael John Sumner
Chief Medical Officer
--

Dr. Laurent Humeau, PhD
Chief Scientific Officer
976.66K

Simon X. Benito
Chairman of the Board
151.19K

Dr. David B. Weiner, PhD
Director
201.79K

Wendy L. Yarno, M.B.A.
Independent Director
123.69K

Jay P. Shepard
Independent Director
119.31K

Dr. Roger D. Dansey, M.D.
Independent Director
108.69K

Dr. Ann C. Miller, M.D.
Independent Director
126.94K

Lota S. Zoth, C.P.A.
Independent Director
118.69K

INO Inovio Pharmaceuticals

About Inovio Pharmaceuticals Company

Company Profile

Company Executives

Trending Stocks